| Literature DB >> 19900758 |
Elizabeth Brandon-Warner1, James A Sugg, Laura W Schrum, Iain H McKillop.
Abstract
Chronic ethanol consumption is a known risk factor for developing hepatocellular carcinoma (HCC). The use of plant-derived antioxidants is gaining increasing clinical prominence as a potential therapy to ameliorate the effects of ethanol on hepatic disease development and progression. This study demonstrates silibinin, a biologically active flavanoid derived from milk thistle, inhibits cytochrome p4502E1 induction, ethanol metabolism and reactive oxygen species generation in HCC cells in vitro. These silibinin-mediated effects also inhibit ethanol-dependent increases in HCC cell proliferation in culture. 2009 Elsevier Ireland Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19900758 PMCID: PMC3099213 DOI: 10.1016/j.canlet.2009.10.004
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679